Department of Pharmaceutics, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Str. 3, 53121 Bonn, Germany.
Department of Pharmaceutics, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Str. 3, 53121 Bonn, Germany; PEPITE (EA4267), University of Burgundy/Franche-Comté, Besançon, France.
Int J Pharm. 2018 Jun 10;544(1):213-221. doi: 10.1016/j.ijpharm.2018.03.062. Epub 2018 Apr 6.
The use of various harmful organic solvents for microparticle formulations is still widespread. Here, an alternative low toxicity solvent (propylene carbonate; PC) is proposed for the preparation of poly(lactic-co-glycolic-acid) (PLGA) microparticles. Based on the classical emulsification-solvent extraction methodology, the use of PC offers the unique advantage of an additional solvent extraction step using hydrolytic solvent cleavage during microparticle preparation. Spherical, rough-surfaced microparticles were obtained with a volume median diameter range from 20 to 60 µm. The residual PC content has been identified to be the major factor for the solidification hindrance, leading to polymeric Tg shifting due to a plasticizing effect. When applying the enhanced PC extraction step, the residual PC content was lowered from 8.8% to 2.7% and subsequently Tg values shifted from 8.2 to 37.7 °C. Additionally, the hydrolytic solvent cleavage confirmed to have no impact on the PLGA stability. This method presents a significant advancement towards replacing of conventional solvents in the microparticle preparation due to more efficient solvent extraction.
目前仍广泛使用各种有害有机溶剂来制备微粒制剂。本文提出了一种低毒性替代溶剂(碳酸丙烯酯;PC),用于制备聚(乳酸-共-乙醇酸)(PLGA)微粒。基于经典的乳化-溶剂萃取方法,PC 的使用具有独特的优势,即在微粒制备过程中通过水解溶剂裂解进行额外的溶剂萃取步骤。采用 PC 可获得粒径中值范围为 20-60μm 的球形、表面粗糙的微粒。残留的 PC 含量被认为是阻碍固化的主要因素,导致由于塑化作用使聚合物的玻璃化转变温度(Tg)发生偏移。当采用增强的 PC 萃取步骤时,残留的 PC 含量从 8.8%降低至 2.7%,随后 Tg 值从 8.2°C 偏移至 37.7°C。此外,水解溶剂裂解证实对 PLGA 的稳定性没有影响。该方法由于溶剂萃取效率更高,因此在微粒制备中替代传统溶剂方面具有重要意义。